CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 340 enrolled
Drug / intervention
Claritindrug
Likely dose
Claritin 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01451996
NCT01451996Phase 4Completed
CompareCT.gov

The Efficacy of Claritin in Healthy Subjects

University of Chicago·interventional·Posted Oct 14, 2011·Updated Mar 13, 2018

In Brief

A Phase 4 clinical trial evaluating Claritin for Healthy. Completed, enrolled 340 participants across 1 site.

Detailed Summary

The primary goal of this study is to examine determinants of the efficacy of Claritin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 14, 2011
Enrollment StartOct 1, 2011
Primary CompletionJul 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 14.7 years ago

Interventions

Claritindrug

Subject will be given 10mg Claritin tablet.